TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
Gary A. Rosenberg(University of New Mexico), William G. Stetler‐Stevenson(University of Maryland, Baltimore), Robert O. Kelley(University of New Mexico), Mario Kornfeld(Creativ-Ceutical (France)), Lance A. Liotta(George Mason University), Edward Y. Estrada(Veterans Health Administration)
Cited by 282
Related Papers
National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
|Stroke|2006|1.7k
Neuroinflammation: friend and foe for ischemic stroke
|Journal of Neuroinflammation|2019|1.4k
Collagenase-induced intracerebral hemorrhage in rats.
|Stroke|1990|607
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
|Cancer|1984|397
Devic's neuromyelitis optica: A clinicopathological study of 8 patients
|Annals of Neurology|1993|335